In The News
Elena Baltacha dies aged 30 just two months after revealing liver cancer diagnosis
Elena Baltacha dies aged 30 just two months after revealing liver cancer diagnosis Former British number one tennis champion Elena Baltacha dies aged 30 just two months after revealing liver cancer diagnosis as husband says he is ‘heartbroken beyond words’ Tennis star revealed she was battling cancer in statement in March Agents have confirmed she…
Read MoreScientists Make Critical End-Stage Liver Disease Discovery
Scientists At The UA Make Critical End-Stage Liver Disease Discovery April 28, 2014 The discovery of an unknown cellular pathway has helped scientists and physicians better understand end-stage liver disease and offers a potential target for new therapeutics A team of researchers in the University of Arizona’s College of Pharmacy has discovered a molecular pathway…
Read MoreThe cure for hepatitis C is upon us
The cure for hepatitis C is upon us, but at a costly penny ANDRÉ PICARD (Corrected version) The Globe and Mail Published Sunday, Apr. 27 2014, 4:00 PM EDT Last updated Sunday, Apr. 27 2014, 10:33 PM EDT There is a revolution coming to the treatment of hepatitis C. But a big fat asterisk is…
Read MoreDeaths from liver disease soar 40 per cent in a decade
Deaths from liver disease have soared by 40 per cent in a decade and will continue to rise because of heavy drinking and unhealthy eating, a report warns today.
Read MoreNew Liver Drug Big News for Intercept
New Liver Drug Big News for Intercept Intercept Pharmaceuticals, Inc reported big news, that its new liver drug, obeticolic acid (OCA), can effectively treat primary biliary cirrhosis (PBC), an autoimmune disease that damages bile ducts in the liver. The findings bring the company a step closer to filing for market approval. Intercept is unique for…
Read MoreLiving With Auto-Immune Heptatitis
Living With Auto-Immune Heptatitis Comments (0) Out of the blue, Marina Barlow developed a yellow hue to her skin – jaundice – and found herself in the Bristol Royal Infirmary for a week where doctors diagnosed auto-immune hepatitis, for which there is no cure. So Marina, who is 29 and lives in Filton, is stuck with…
Read MoreNew Drug Combo Cures Toughest Cases of Hepatitis C, Hints to Future Injection-Free Therapies
Hints to Future Injection-Free Therapies 5 hours ago0 Comments Posted in News, Hepatitis, Research Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective, according to new research at Johns Hopkins and elsewhere. In a study to be…
Read MoreRegulation of Vitamins: Politics As Usual
Regulation of Vitamins: Politics As Usual Commentary by Rolf Hefti (OMNS Jan 7, 2014) Medical politics has been pervaded with unfounded, misleading arguments, tantamount to propaganda, instead of good evidence. Over the last several decades, the US mainstream medical establishment and the public health authorities, along with the help of the medical industry-sponsored mass media,…
Read MoreFDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection
FDA approves OLYSIO (simeprevir) Janssen Therapeutics, Division of Janssen Products, LP (Janssen), announced today the U.S. Food and Drug Administration (FDA) has approved OLYSIO™ (simeprevir), an NS3/4A protease inhibitor, for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with pegylated interferon and ribavirin in genotype 1 infected…
Read MoreFDA approves new treatment for hepatitis C virus
FDA approves new treatment for hepatitis C virus FDA NEWS RELEASE For Immediate Release: Nov. 22, 2013 Media Inquiries: Stephanie Yao, 301-796-0394, stephanie.yao@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA FDA approves new treatment for hepatitis C virus The U.S. Food and Drug Administration today approved Olysio (simeprevir), a new therapy to treat chronic hepatitis C virus infection. Hepatitis…
Read More